1,006
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

High facility-level serum potassium variability associated with mortality in hemodialysis patients: results from Chinese Dialysis Outcomes and Practice Patterns Study (DOPPS)

, , , , , , ORCID Icon & show all
Article: 2211157 | Received 12 Dec 2022, Accepted 02 May 2023, Published online: 09 Jun 2023

References

  • Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):1–10.
  • Yang C, Gao B, Zhao X, et al. Executive summary for China Kidney Disease Network (CK-NET) 2016 annual data report. Kidney Int. 2020;98(6):1419–1423.
  • Zhao X, Niu Q, Gan L, et al. Blood flow rate: an independent risk factor of mortality in Chinese hemodialysis patients. Semin Dial. 2022;35(3):251–257.
  • Zhao X, Niu Q, Gan L, et al. Thrombocytopenia predicts mortality in Chinese hemodialysis patients–an analysis of the China DOPPS. BMC Nephrol. 2022;23(1):11.
  • Niu Q, Zhao X, Gan L, et al. Physical function and clinical outcomes in hemodialysis patients: China Dialysis Outcomes and Practice Patterns Study. Kidney Dis. 2021;7(4):315–322.
  • Genovesi S, Boriani G, Covic A, et al. Sudden cardiac death in dialysis patients: different causes and management strategies. Nephrol Dial Transplant. 2021;36(3):396–405.
  • United States Renal Data System. USRDS annual data report: epidemiology of kidney disease in the United States; 2018. Available from: https://www.usrds.org/adr.aspx
  • Kovesdy CP, Regidor DL, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(5):999–1007.
  • Yusuf AA, Hu Y, Singh B, et al. Serum potassium levels and mortality in hemodialysis patients: a retrospective cohort study. Am J Nephrol. 2016;44(3):179–186.
  • Lee S, Kang E, Yoo KD, et al. Lower serum potassium associated with increased mortality in dialysis patients: a nationwide prospective observational cohort study in Korea. PLOS One. 2017;12(3):e0171842.
  • Hwang JC, Wang CT, Chen CA, et al. Hypokalemia is associated with increased mortality rate in chronic hemodialysis patients. Blood Purif. 2011;32(4):254–261.
  • Karaboyas A, Zee J, Brunelli SM, et al. Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2017;69(2):266–277.
  • Agar BU, Culleton BF, Fluck R, et al. Potassium kinetics during hemodialysis. Hemodial Int. 2015;19(1):23–32.
  • Brunelli SM, Spiegel DM, Du Mond C, et al. Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients. Nephrol Dial Transplant. 2018;33(7):1207–1214.
  • Ohnishi T, Kimachi M, Fukuma S, et al. Postdialysis hypokalemia and all-cause mortality in patients undergoing maintenance hemodialysis. Clin J Am Soc Nephrol. 2019;14(6):873–881.
  • Szeto C-C, Chow K-M, Kwan BC-H, et al. Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication. Am J Kidney Dis. 2005;46(1):128–135.
  • Xu Q, Xu F, Fan L, et al. Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortality. PLOS One. 2014;9(1):e86750.
  • Dashputre AA, Potukuchi PK, Sumida K, et al. Predialysis potassium variability and postdialysis mortality in patients with advanced CKD. Kidney Int Rep. 2021;6(2):366–380.
  • Pisoni RL, Bragg-Gresham JL, Fuller DS, et al. Facility-level interpatient hemoglobin variability in hemodialysis centers participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS): associations with mortality, patient characteristics, and facility practices. Am J Kidney Dis. 2011;57(2):266–275.
  • Zhao X, Niu Q, Gan L, et al. Baseline data report of the China Dialysis Outcomes and Practice Patterns Study (DOPPS). Sci Rep. 2021;11(1):873.
  • Li SH, Xie JT, Long HB, et al. Time-averaged serum potassium levels and its fluctuation associate with 5-year survival of peritoneal dialysis patients: two-center based study. Sci Rep. 2015;5:15743.
  • Yin S, Du Y, Guo Y, et al. Multifactorial analysis of renal anemia-associated substandard hemoglobin levels and prevalence of anemia in patients on maintenance hemodialysis in Liaoning province: a cross-sectional study. Ann Palliat Med. 2022;11(12):3743–3754.
  • Wang HH, Hung CC, Hwang DY, et al. Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease. PLOS One. 2013;8(7):e67140.
  • Mercadal L, Lambert O, Couchoud C, et al. Prescription patterns of dialysate potassium and potassium binders and survival on haemodialysis—the French Renal Epidemiology and Information Network Registry. Nephrol Dial Transplant. 2021;36(1):151–159.
  • He H, Wu J, Lu W, et al. A multicenter study of hemodialysis using individualized dialysate potassium concentrations. Ann Palliat Med. 2021;10(12):12218–12229.
  • Lin X, Gu L, Zhu M, et al. Clinical outcome of twice-weekly hemodialysis patients with long-term dialysis vintage. Kidney Blood Press Res. 2018;43(4):1104–1112.
  • Fang N, Che M, Shi L, et al. B-type natriuretic peptide levels and volume status in twice-weekly hemodialysis patients. Ren Fail. 2021;43(1):1259–1265.
  • Sun Y, Wang Y, Yu W, et al. Association of dose and frequency on the survival of patients on maintenance of hemodialysis in China: a Kaplan–Meier and Cox-proportional hazard model analysis. Med Sci Monit. 2018;24:5329–5337.
  • Yan Y, Wang M, Zee J, et al. Twice-weekly hemodialysis and clinical outcomes in the China Dialysis Outcomes and Practice Patterns Study. Kidney Int Rep. 2018;3(4):889–896.
  • Panaput T, Thinkhamrop B, Domrongkitchaiporn S, et al. Dialysis dose and risk factors for death among ESRD patients treated with twice-weekly hemodialysis: a prospective cohort study. Blood Purif. 2014;38(3–4):253–262.
  • Bem D, Sugrue D, Wilding B, et al. The effect of hyperkalemia and long inter-dialytic interval on morbidity and mortality in patients receiving hemodialysis: a systematic review. Ren Fail. 2021;43(1):241–254.
  • Su G, Saglimbene V, Wong G, et al. Healthy lifestyle and mortality among adults receiving hemodialysis: the DIET-HD study. Am J Kidney Dis. 2022;79(5):688–698.e1.
  • Saglimbene VM, Wong G, Teixeira-Pinto A, et al. Dietary patterns and mortality in a multinational cohort of adults receiving hemodialysis. Am J Kidney Dis. 2020;75(3):361–372.
  • Fisher M, Golestaneh L, Allon M, et al. Prevention of bloodstream infections in patients undergoing hemodialysis. Clin J Am Soc Nephrol. 2020;15(1):132–151.